» Articles » PMID: 24204772

Increased Risk of Primary Sjögren's Syndrome in Female Patients with Thyroid Disorders: a Longitudinal Population-based Study in Taiwan

Overview
Journal PLoS One
Date 2013 Nov 9
PMID 24204772
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: A number of reports have indicated an association between thyroid diseases and primary Sjögren's syndrome (pSS). However, fewer studies have investigated whether the presence of thyroid diseases is associated with increased risk of developing pSS. Thus, the aim of our study was to use a nationwide health claims database to explore the prevalence and risk of pSS in female patients with thyroid diseases.

Methods: From the Registry of Catastrophic Illness database in the National Health Insurance Research Database in Taiwan, we identified 389 female patients with a diagnosis of pSS from 2005 to 2010. We also obtained 1945 control subjects frequency-matched on sex, 10-year age interval, and year of index date from the Longitudinal Health Insurance Database (LHID2000). Both groups were retrospectively traced back to a period of eight years to obtain diagnosis of thyroid diseases prior to index date.

Results: A significantly higher risk of pSS was associated with the presence of thyroid diseases (adjusted odds ratio (AOR) = 2.1, 95% confidence interval (CI) = 1.6-2.9). Among the sub-categories of thyroid diseases, patients with thyroiditis (AOR = 3.6, 95% CI = 1.7-7.5), thyrotoxicosis (AOR = 2.5, 95% CI = 1.6-3.8), and unspecified hypothyroidism (AOR = 2.4, 95% CI = 1.2-4.6), and simple and unspecified goiter (AOR = 2.0, 95% CI = 1.3-3.3) were significantly associated with increased risk of pSS. The associations were generally stronger in the mid-forties to mid-sixties age group, except in patients with unspecified hypothyroidism.

Conclusions: The risk of pSS was significantly increased in female patients with thyroid diseases, particularly those in their mid-forties to mid-sixties. An increased awareness of the possibility of pSS in perimenopausal females with thyroid diseases is important to preserve their quality of life and to avoid comorbidity.

Citing Articles

Risk analysis of breast cancer and breast fibrocystic change in female primary Sjögren's syndrome patients.

Chen H, Chung J, Lin S Medicine (Baltimore). 2023; 102(51):e36769.

PMID: 38134080 PMC: 10735118. DOI: 10.1097/MD.0000000000036769.


Analysis of Hepatitis D Virus in Minor Salivary Gland of Sjögren's Disease.

Hesterman M, Furrer S, Fallon B, Weller M J Dent Res. 2023; 102(11):1272-1279.

PMID: 37575047 PMC: 10626587. DOI: 10.1177/00220345231186394.


Increased Threat of Thyroid Diseases in Patients With Sjogren's Syndrome: A Systematic Review.

Kaur H, Alazzeh M, Thandavaram A, Channar A, Purohit A, Shrestha B Cureus. 2022; 14(8):e28062.

PMID: 36120277 PMC: 9477098. DOI: 10.7759/cureus.28062.


Association between Anti-Hepatitis C Viral Intervention Therapy and Risk of Sjögren's Syndrome: A National Retrospective Analysis.

Tung C, Chen Y, Chen Y J Clin Med. 2022; 11(15).

PMID: 35893350 PMC: 9332495. DOI: 10.3390/jcm11154259.


Increased risk of thyroid disease in patients with Sjogren's syndrome: a systematic review and meta-analysis.

Sun X, Lu L, Li Y, Yang R, Shan L, Wang Y PeerJ. 2019; 7:e6737.

PMID: 30918763 PMC: 6430100. DOI: 10.7717/peerj.6737.


References
1.
Peri Y, Agmon-Levin N, Theodor E, Shoenfeld Y . Sjögren's syndrome, the old and the new. Best Pract Res Clin Rheumatol. 2012; 26(1):105-17. DOI: 10.1016/j.berh.2012.01.012. View

2.
Bjoro T, Holmen J, Kruger O, Midthjell K, Hunstad K, Schreiner T . Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trondelag (HUNT). Eur J Endocrinol. 2000; 143(5):639-47. DOI: 10.1530/eje.0.1430639. View

3.
Gudbjornsson B, Karlsson-Parra A, Karlsson E, Hallgren R, Kampe O . Clinical and laboratory features of Sjögren's syndrome in young women with previous postpartum thyroiditis. J Rheumatol. 1994; 21(2):215-9. View

4.
Kang J, Lin H . Comorbidities in patients with primary Sjogren's syndrome: a registry-based case-control study. J Rheumatol. 2010; 37(6):1188-94. DOI: 10.3899/jrheum.090942. View

5.
Coll J, Anglada J, Tomas S, Reth P, Goday A, Millan M . High prevalence of subclinical Sjögren's syndrome features in patients with autoimmune thyroid disease. J Rheumatol. 1997; 24(9):1719-24. View